Persistent Associations between Maternal Prenatal Exposure to Phthalates on Child IQ at Age 7 Years
Pam Factor-Litvak1, Beverly Insel1, Antonia M Calafat2
1Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Insights
Maternal exposure to di-n-butyl phthalate (DnBP) and di-isobutyl phthalate (DiBP) during pregnancy is linked to lower IQ in children by age 7. These findings highlight the public health impact of ubiquitous phthalate exposure on child development.
Area of Science:
- Environmental Health
- Developmental Toxicology
- Neuroscience
Background:
- Previous studies indicated prenatal phthalate exposure negatively impacts preschooler development.
- Research gaps existed regarding the persistence of these effects into school-age years.
Purpose of the Study:
- To investigate the association between maternal prenatal phthalate metabolite concentrations and cognitive development in school-aged children.
- To determine if previously observed associations in preschoolers extend to 7-year-olds.
Main Methods:
- Follow-up study of 328 inner-city mother-child pairs.
- Measurement of prenatal urinary phthalate metabolites (DnBP, BBzP, DiBP, etc.) in late pregnancy.
- Cognitive function assessed at age 7 using the Wechsler Intelligence Scale for Children (WISC-IV).
Main Results:
- Prenatal DnBP and DiBP metabolite concentrations were inversely associated with child full-scale IQ (IQ).
- Children in the highest quartile of DnBP/DiBP exposure had significantly lower IQ scores compared to the lowest quartile.
- Associations remained significant after controlling for earlier cognitive development and affected specific cognitive domains like processing speed and verbal comprehension.
Conclusions:
- Maternal prenatal exposure to DnBP and DiBP is associated with intellectual deficits in 7-year-old children.
- Given the widespread nature of phthalate exposure, these findings have significant public health implications for child development.
Background:
Prior research reports inverse associations between maternal prenatal urinary phthalate metabolite concentrations and mental and motor development in preschoolers. No study evaluated whether these associations persist into school age.
Methods:
In a follow up of 328 inner-city mothers and their children, we measured prenatal urinary metabolites of di-n-butyl phthalate (DnBP), butylbenzyl phthalate (BBzP), di-isobutyl phthalate (DiBP), di-2-ethylhexyl phthalate and diethyl phthalate in late pregnancy. The Wechsler Intelligence Scale for Children, 4th edition was administered at child age 7 years and evaluates four areas of cognitive function associated with overall intelligence quotient (IQ).
Results:
Child full-scale IQ was inversely associated with prenatal urinary metabolite concentrations of DnBP and DiBP: b = -2.69 (95% confidence interval [CI] = -4.33, -1.05) and b = -2.69 (95% CI = -4.22, -1.16) per log unit increase. Among children of mothers with the highest versus lowest quartile DnBP and DiBP metabolite concentrations, IQ was 6.7 (95% CI = 1.9, 11.4) and 7.6 (95% CI = 3.2, 12.1) points lower, respectively. Associations were unchanged after control for cognition at age 3 years. Significant inverse associations were also seen between maternal prenatal metabolite concentrations of DnBP and DiBP and child processing speed, perceptual reasoning and working memory; DiBP and child verbal comprehension; and BBzP and child perceptual reasoning.
Conclusion:
Maternal prenatal urinary metabolite concentrations measured in late pregnancy of DnBP and DiBP are associated with deficits in children's intellectual development at age 7 years. Because phthalate exposures are ubiquitous and concentrations seen here within the range previously observed among general populations, results are of public health significance.
More Related Videos
Related Concept Videos
Environmental Influences on Intelligence
Biological Influences on Intelligence
Intellectual Disability
Information Processing Approach
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Socioemotional Development during Infancy
Primary Temperament Types


